KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy

Yang Li, Chao Lv, Yang Yu, Baokang Wu, Yizhou Zhang, Qi Lang, Zhiyun Liang, Chongli Zhong, Yu Shi, Shukun Han, Feng Xu, Yu TianJournal of Advanced Research 2022 · DOI

Abstract

KIR3DL3/TMIGD2-HHLA2 may represent novel pathways within the tumour microenvironment and serve as crucial immune checkpoints for developing novel therapeutic drugs against human cancer.
BibTeX
@article{li2022kir,
  author = {Yang Li and Chao Lv and Yang Yu and Baokang Wu and Yizhou Zhang and Qi Lang and Zhiyun Liang and Chongli Zhong and Yu Shi and Shukun Han and Feng Xu and Yu Tian},
  title = {{KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy}},
  journal = {Journal of Advanced Research},
  year = {2022},
  doi = {10.1016/j.jare.2022.07.013},
}

Loading related content...

Figure